T Hashimoto-Gotoh

Author PubWeight™ 41.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 High-copy-number and low-copy-number plasmid vectors for lacZ alpha-complementation and chloramphenicol- or kanamycin-resistance selection. Gene 1987 9.16
2 Specific-purpose plasmid cloning vectors. I. Low copy number, temperature-sensitive, mobilization-defective pSC101-derived containment vectors. Gene 1981 5.96
3 Mutations of temperature sensitivity in R plasmid pSC101. J Bacteriol 1977 2.38
4 New cosmid vectors developed for eukaryotic DNA cloning. Gene 1984 1.97
5 ColE1 plasmid incompatibility: localization and analysis of mutations affecting incompatibility. J Bacteriol 1979 1.64
6 Location of two relaxation nick sites in R6K and single sites in pSC101 and RSF1010 close to origins of vegetative replication: implication for conjugal transfer of plasmid deoxyribonucleic acid. J Bacteriol 1980 1.40
7 Random replication and random assortment model for plasmid incompatibility in bacteria. Plasmid 1978 1.39
8 A bovine papilloma virus vector with a dominant resistance marker replicates extrachromosomally in mouse and E. coli cells. EMBO J 1983 1.33
9 Incompatibility properties of Col E1 and pMB1 derivative plasmids: random replication of multicopy replicons. Cell 1981 1.32
10 Isolation and characterization of replication-deficient mutants of ColE1 plasmids. J Bacteriol 1979 1.09
11 Structure of human alpha 2-plasmin inhibitor deduced from the cDNA sequence. J Biochem 1987 1.04
12 Identification of the principal promoter sequence of the c-H-ras transforming oncogene: deletion analysis of the 5'-flanking region by focus formation assay. Mol Cell Biol 1987 1.00
13 Isolation of mouse and human cDNA clones encoding a protein expressed specifically in osteoblasts and brain tissues. Biochem Biophys Res Commun 1990 0.97
14 Cloning of human and mouse cDNAs encoding novel zinc finger proteins expressed in cerebellum and hippocampus. Biochem Biophys Res Commun 1997 0.96
15 Bone mass loss due to estrogen deficiency is compensated in transgenic mice overexpressing human osteoblast stimulating factor-1. Biochem Biophys Res Commun 1997 0.94
16 Improved vector, pHSG664, for direct streptomycin-resistance selection: cDNA cloning with G:C-tailing procedure and subcloning of double-digest DNA fragments. Gene 1986 0.93
17 An improved system for selection of forward mutations in an Escherichia coli supF gene carried by plasmids. J Radiat Res 1998 0.84
18 Characterization of the spontaneous elimination of streptomycin sensitivity (SmS) on high-copy-number plasmids: SmS-enforcement cloning vectors with a synthetic rpsL gene. Gene 1992 0.83
19 Tandem gene amplification in vitro for rapid and efficient expression in animal cells. Gene 1988 0.82
20 Congenital antithrombin III deficiency (AT-III Kyoto): identification of a point mutation altering arginine-406 to methionine behind the reactive site. Thromb Res 1991 0.80
21 Nonsense mutation in factor VIII gene of a severe haemophiliac patient with anti-factor VIII antibody. Jinrui Idengaku Zasshi 1988 0.79
22 Cloning of Xenopus presenilin-alpha and -beta cDNAs and their differential expression in oogenesis and embryogenesis. Biochem Biophys Res Commun 1997 0.78
23 Temperature sensitive replication plasmids are passively distributed during cell division at non-permissive temperature: a new model for replicon duplication and partitioning. Mol Gen Genet 1982 0.77
24 Developmental and differential regulations in gene expression of Xenopus pleiotrophic factors-alpha and -beta. Biochem Biophys Res Commun 1995 0.76
25 Isolation and characterization of a mouse protein C cDNA. J Biochem 1992 0.76
26 Hydrophobic residues 382-386 of antithrombin III, Ala-Ala-Ala-Ser-Thr, serve as the epitope for an antibody which facilitates hydrolysis of the inhibitor by thrombin. J Biol Chem 1990 0.75
27 The DNA-binding activities of NF-AT and AP-1 can predict levels of immunosuppression of kidney transplant recipients. Transplant Proc 1997 0.75
28 A novel monitoring of immunosuppression in recipients with DNA-binding activity of nuclear factor in activated T cells. Transplant Proc 1997 0.75